Table 3.

Median and range of SARS-CoV-2 antibody titrations (in BAU/mL)/number of patients assessed, following the 1st vaccine injection. The results are presented for CPs and HCWs in relation to the occurrence of SARS-CoV-2 infection after vaccination during the follow-up.

Time from First Vaccine Injection to Titration	Population	Infection after Vaccination	No Infection after Vaccination	p Value
0 to 3 months	CP	551.5 (<4.81; >2080)/40	352.5 (<4.81; >2080)/620	0.605
0 to 3 months	HCW	384.5 (<4.81; >2080)/40	722 (<4.81; >2080)/837	0.402
3 to 6 months	CP	746.5 (<4.81; >2080)/20	631.5 (<4.81; >2080)/458	0.604
3 to 6 months	HCW	1935 (<4.81; >2080)/22	1310 (<4.81; >2080)/719	0.614
over 6 months	CP	402 (<4.81; >2080)/19	398 (<4.81; >2080)/321	0.414
over 6 months	HCW	992 (<4.81; >2080)/18	580.5 (12; >2080)/418	0.111

CP: cancer patients; HCW: health care workers.